T1	disease_or_phenotypic_feature 55 61	mutant
T2	chemical 89 100	simvastatin
T3	chemical 146 155	inhibitor
T4	chemical 156 165	cetuximab
T5	chemical 189 199	inhibitors
T6	disease_or_phenotypic_feature 204 217	heart failure
T7	chemical 230 240	anesthesia
T8	disease_or_phenotypic_feature 244 252	cataract
T9	chemical 292 302	biomarkers
T10	disease_or_phenotypic_feature 415 426	early tumor
T11	chemical 510 521	biochemical
T12	disease_or_phenotypic_feature 587 598	hypokalemic
T13	disease_or_phenotypic_feature 599 617	hyperaldosteronism
T14	chemical 620 630	Fluoxetine
T15	disease_or_phenotypic_feature 635 641	autism
T16	chemical 676 683	heparin
T17	disease_or_phenotypic_feature 798 808	congenital
T18	chemical 843 857	Spironolactone
T19	chemical 862 884	aldosterone antagonist
T20	chemical 926 936	inhibitors
T21	disease_or_phenotypic_feature 961 974	heart failure
T22	chemical 1039 1046	biology
T23	disease_or_phenotypic_feature 1050 1063	neuroblastoma
T24	chemical 1126 1133	biology
T25	chemical 1186 1194	estrogen
T26	chemical 1266 1278	biologically
T27	chemical 1289 1298	estradiol
T28	disease_or_phenotypic_feature 1329 1336	obesity
T29	chemical 1432 1440	estrogen
T30	chemical 1445 1457	progesterone
T31	chemical 1469 1485	Ticagrelor-based
T32	disease_or_phenotypic_feature 1541 1557	artery disease-A
T33	chemical 1630 1639	midazolam
T34	disease_or_phenotypic_feature 1680 1688	cataract
T35	chemical 1710 1720	anesthesia
T36	chemical 1737 1747	budesonide
T37	chemical 1751 1755	drug
T38	disease_or_phenotypic_feature 1776 1787	lung tumors
T39	disease_or_phenotypic_feature 1844 1855	lung tumors
T40	chemical 1877 1887	Fluoxetine
T41	disease_or_phenotypic_feature 1929 1935	autism
T42	disease_or_phenotypic_feature 1978 1989	hypophyseal
T43	chemical 2006 2014	estrogen
T44	chemical 2040 2050	anesthesia
T45	disease_or_phenotypic_feature 2069 2078	cleft lip
T46	disease_or_phenotypic_feature 2083 2095	cleft palate
T47	chemical 2107 2117	hemoglobin
T48	chemical 2118 2124	oxygen
T49	disease_or_phenotypic_feature 2151 2163	pancreatitis
T50	disease_or_phenotypic_feature 2193 2213	hyperlipoproteinemia
T51	chemical 2221 2232	Angiotensin
T52	chemical 2240 2251	antagonists
T53	disease_or_phenotypic_feature 2283 2296	heart failure
T54	disease_or_phenotypic_feature 2338 2345	non-CKD
T55	chemical 2359 2364	group
T56	chemical 2387 2392	group
T57	chemical 2415 2420	group
T58	disease_or_phenotypic_feature 2496 2500	rare
T59	disease_or_phenotypic_feature 2501 2506	tumor
T60	chemical 2616 2623	biology
T61	missed_chemical 34 38	KRAS
T62	corrected_disease_or_phenotypic_feature 50 68	KRAS mutant tumors
R1	treats Arg1:T2 Arg2:T62	
T63	corrected_chemical 167 199	Phosphodiesterase III inhibitors
T64	missed_chemical 314 327	nucleic acids
T65	missed_chemical 329 337	proteins
T66	missed_chemical 339 352	carbohydrates
T67	missed_disease_or_phenotypic_feature 739 747	bleeding
R2	treats Arg1:T16 Arg2:T67	
R3	treats Arg1:T18 Arg2:T21	
R4	treats Arg1:T19 Arg2:T21	
T68	corrected_chemical 922 936	ACE inhibitors
R5	treats Arg1:T68 Arg2:T21	
T69	missed_disease_or_phenotypic_feature 1355 1376	breast carcinogenesis
T70	missed_disease_or_phenotypic_feature 1643 1650	anxiety
R6	treats Arg1:T36 Arg2:T38	
T71	corrected_chemical 2215 2251	Renin-Angiotensin system antagonists
T72	missed_disease_or_phenotypic_feature 2346 2358	hypertensive
T73	DONE 2642 2646	DONE
